Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil versus prednisolone as initial treatment for idiopathic membranous nephropathy
IRCT20180128038539N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of mycophenolate mofetil and prednisolone in idiopathic membranous glomerulonephritis (IMG) and nephritic syndrome (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Urine protein, Albumin and 2 more. Started Jul 2014; status: completed.
02
Drugs
mycophenolate mofetilprednisolone
03
Conditions
idiopathic membranous glomerulonephritis (IMG)nephritic syndrome
Beyond the preview
Go deeper on IRCT20180128038539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180128038539N1.